My watch list
my.bionity.com  
Login  
NEWS
Current news

A major step forward in fight against Chikungunya fever

The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information of the trial has been presented at two international conferences. Th ... more

AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational

AMRI announced that its Albuquerque, N.M. sterile injectable facility has resumed full manufacturing operations. As previously announced, in September 2014 AMRI identified an environmental deviation in one manufacturing suite as a result of a weather related business interruption. The resul ... more

The role DNA methylation plays in aging cells

Although every person's DNA remains the same throughout their lives, scientists know that it functions differently at different ages. As people age, drastic changes occur in their DNA methylation patterns, which are thought to act as a "second code" on top of the DNA that can lock genes in ... more

Clean energy 'bio batteries' a step closer

Researchers from the University of East Anglia (UEA) are a step closer to enhancing the generation of clean energy from bacteria. A report published shows how electrons hop across otherwise electrically insulating areas of bacterial proteins, and that the rate of electrical transfer is depe ... more

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

Sanofi and Regeneron Pharmaceuticals, Inc. announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol (LDL-C, or "bad" cholesterol). Alirocumab is an investigational fully human monoclonal antibody ... more

New insights from the Mouse ENCODE Project published in Genome Research

Genome Research publishes three articles in conjunction with articles published in other journals describing recent advances from the Mouse ENCODE Project Consortium. Initially launched to complement the human Encyclopedia of DNA Elements (ENCODE) Project in 2008, the Mouse ENCODE Project a ... more

Financial support up to 30.000€ for SME’s developing biobased innovations

SME’s can access ‘Innovation Coupons’ worth up to 30.000€ to assess the feasibility of an innovative biobased process at Bio Base Europe Pilot Plant in Ghent, Belgium. These Innovation Coupons are an initiative of Bio Base NWE, a project to support the development of the bio-based economy i ... more

Antibiotics get a “time-out”

Resistance to antibiotics is an important health concern that affects both the spread of infections, like Clostridium difficile, and the medication budget. Researchers at the McGill University Health Centre (MUHC) examined the effectiveness of adopting an antibiotic “time-out” during treatm ... more

Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe

Dyax Corp. announced that it has been named one of the Top Places to Work in Massachusetts by The Boston Globe."Great people build great businesses. At Dyax, our employees are the foundation of our organization and are behind our steady growth and winning culture," said Gustav Christensen, ... more

New insights that link Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD)

Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein). Scie ... more

All news

Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe

Dyax Corp. announced that it has been named one of the Top Places to Work in Massachusetts by The Boston Globe."Great people build great businesses. At Dyax, our employees are the foundation of our organization and are behind our steady growth and winning culture," said Gustav Christensen, ... more

Eurofins Genomics Achieves GLP Certification

Eurofins Genomics has now achieved Good Laboratory Practice (GLP) certification for DNA sequencing services, the first genomic service provider in Germany to attain such qualification.Good Laboratory Practice is a required standard for laboratories conducting non-clinical safety studies, fo ... more

Failed Alzheimer’s test shows in which direction the research should continue

Disappointing results in clinical Alzheimer’s studies discourage doctors and scientists from continuing their research into ɣ-secretases and a possible treatment against Alzheimer’s disease. In Cell, the Alzheimer’s expert Bart De Strooper (VIB-KU Leuven) argues that these studies are not p ... more

Nabsys Appoints Anthony Shuber as Chief Scientific Officer

Nabsys, Inc. announced today Anthony Shuber has joined the company as Vice President and Chief Scientific Officer. In this role, Shuber will lead the company’s efforts in product strategy as the company transitions its initial commercial focus toward oncology. Shuber, an industry veteran an ... more

New microscope collects dynamic images of the molecules that animate life

Over the last decade, powerful new microscopes have dramatically sharpened biologists' focus on the molecules that animate and propel life. Now, a new imaging platform developed by Eric Betzig and colleagues at the Howard Hughes Medical Institute's Janelia Research Campus offers another lea ... more

Eppendorf Award for Young European Investigators 2015: Call for entries

Until 15 January 2015, young researchers working in Europe who are not older than 35 years are invited to apply for the Eppendorf Award for Young European Investigators. This prize acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, ... more

Eurofins Genomics Extends Its Genomic Business Into Austria And Czech Republic

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, has now established its own subsidiary in Austria. Customers will be served directly through Eurofins Genomics AT GmbH located in Vienna.The acquisition of the oligonucleotide synthesis and DNA sequencing businesses ... more

New sequencing reveals genetic history of tomatoes

An international team of researchers, led by the Chinese Academy of Agricultural Sciences in Beijing, published in the journal Nature Genetics a brief genomic history of tomato breeding, based on sequencing of 360 varieties of the tomato plant. The C.M. Rick Tomato Genetics Resource Center ... more

Eurofins Genomics Extends Its Genomic Business In Italy

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, has now established its own subsidiary in Italy, located in Vimodrone, Milan. With the acquisition of the oligonucleotide synthesis and DNA sequencing business from Primm S.r.l. in June this year and the decision to ... more

Bibby Scientific Ltd acquires PCRmax Ltd

Bibby Scientific has purchased 100% of the share capital of PCRmax, a UK based sales and distribution Company set up specifically to capture a significant market share of the standard (PCR) and quantitative PCR (QPCR) markets. They are also the registered owners of the intellectual property ... more

All news on bioanalytics

The role DNA methylation plays in aging cells

Although every person's DNA remains the same throughout their lives, scientists know that it functions differently at different ages. As people age, drastic changes occur in their DNA methylation patterns, which are thought to act as a "second code" on top of the DNA that can lock genes in ... more

Clean energy 'bio batteries' a step closer

Researchers from the University of East Anglia (UEA) are a step closer to enhancing the generation of clean energy from bacteria. A report published shows how electrons hop across otherwise electrically insulating areas of bacterial proteins, and that the rate of electrical transfer is depe ... more

New insights from the Mouse ENCODE Project published in Genome Research

Genome Research publishes three articles in conjunction with articles published in other journals describing recent advances from the Mouse ENCODE Project Consortium. Initially launched to complement the human Encyclopedia of DNA Elements (ENCODE) Project in 2008, the Mouse ENCODE Project a ... more

Financial support up to 30.000€ for SME’s developing biobased innovations

SME’s can access ‘Innovation Coupons’ worth up to 30.000€ to assess the feasibility of an innovative biobased process at Bio Base Europe Pilot Plant in Ghent, Belgium. These Innovation Coupons are an initiative of Bio Base NWE, a project to support the development of the bio-based economy i ... more

New insights that link Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD)

Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein). Scie ... more

Evolva to acquire Allylix

Evolva Holding SA has agreed to acquire San Diego-based Allylix, Inc., a privately held yeast fermentation company with a focus on high-value ingredients, in an all-stock transaction. The acquisition will immediately expand Evolva’s product and IP portfolio and enhance the competitiveness o ... more

Ablynx appoints Johan Heylen as Chief Commercial Officer

Ablynx announced the appointment of Johan Heylen as Chief Commercial Officer. Mr Heylen will assume responsibility for all Ablynx's commercial activities. He has more than 20 years of experience in global biopharmaceutical sales, marketing and business development at GlaxoSmithKline (GSK), ... more

Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics

The two U.S. FDA approved oligonucleotide-based drugs on the market both have a modified chemical backbone made of phosphorothioates. The therapeutic advantages of the phosphorothioate group and the new types of gene expression-regulation oligonucleotide drugs that it is enabling are detail ... more

Genetic testing for personalized nutrition leads to better outcomes

Researchers from the University of Toronto (U of T) report that personalized dietary advice based on a person's genetic makeup improves eating habits compared to current "one-size-fits-all" dietary recommendations. The findings were published in PLoS One. "We conducted the first randomized ... more

Unlocking the different tempi of protein synthesis

Scientists of the Max Planck Institutes of Colloids and Interfaces in Potsdam and for Biophysical Chemistry in Göttingen have developed a new method to determine the different codon-specific speeds of protein synthesis in living cells from in-vitro experiments. The proverb ‘life is motion’ ... more

All news on biotechnology

Towards future lab-on-chip applications

Smart and portable medical equipment is essential for fast and easy point-of-care and point-of-use diagnostics. Lab-on-a-chip applications in hand-held devices can help to save time for laboratory medical analysis in emergency scenarios. The combination of sub-micrometer-thick light emittin ... more

Humedics closes 6.3 million € financing round

Humedics GmbH announced the closing of a Series C financing round totaling more than 6.3 million Euro. Humedics’ business model, products and company development has attracted new international investors that will join the current private and public investors.The financing round was led by ... more

Failed Alzheimer’s test shows in which direction the research should continue

Disappointing results in clinical Alzheimer’s studies discourage doctors and scientists from continuing their research into ɣ-secretases and a possible treatment against Alzheimer’s disease. In Cell, the Alzheimer’s expert Bart De Strooper (VIB-KU Leuven) argues that these studies are not p ... more

bioLytical develops 60-second Ebola testing kit

bioLytical Laboratories has successfully developed a pre-clinical prototype diagnostic test for the rapid detection of antibodies to the Ebola Zaire strain responsible for the current outbreak in West Africa. The prototype is based upon the Company's proven, accurate, and highly accepted IN ... more

Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents

Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen's product candidates. Under this agreement, the compani ... more

QIAGEN announces broad agreement with Astellas Pharma to develop companion diagnostics

QIAGEN N.V.  announced a master collaboration agreement with Astellas Pharma Inc. to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of the agreement is not restricted to certain sample types, platforms, indications ... more

Preventing Shock

Clinical shock is one of the most common causes of the high mortality rate among critically-ill patients in Intensive Care Units. During shock, the transport of oxygenated blood is not sufficient to meet the metabolic demands of the tissue. Early detection is important as shock-preventing m ... more

Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer

Researchers at VTT Technical Research Centre of Finland, the University of Turku and the University of Oslo have discovered a previously unknown molecular-level mechanism that may partly explain the increased growth of cancer cells. The study, published in the British Journal of Cancer, sho ... more

New clues for the early detection of colorectal cancer

Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new “biomarkers”: molecules whose increased presence or absence in tissue suggests the development of tumo ... more

New blood test determines whether you have or are likely to get cancer

A new research report published in the October 2014 issue of The FASEB Journal may make the early detection of cancer as easy as a simple blood test. This test, called the "lymphocyte genome sensitivity" (LGS) test, could not only detect some cancers earlier than ever before, but it may eli ... more

All news on diagnostics

LAUDA founds subsidiary in Italy

The constant temperature equipment specialist LAUDA is expanding its international reach with the creation of LAUDA Italia. The purpose of the 100% subsidiary of LAUDA Beteiligungs-GmbH is to manage the increased expansion of business in the important European market. "In this company decis ... more

analytica China 2014: Closed with overall success

On September 26 analytica China 2014 closed with record-breaking visitor numbers: 18,775 business professionals (2012: 16,940) from 62 countries attended the seventh edition of Chinas Leading Trade Fair for Laboratory Technology, Analysis, Biotechnology and Diagnostics at the Shanghai New I ... more

Messe München International takes over one of India's leading trade fairs for laboratory technology

Messe München International is strengthening its portfolio of events in the future market of India by taking over India Lab Expo, one of the leading trade fairs for laboratory technology, analysis and biotechnology on the Indian subcontinent. For the first time ever, this year's India Lab E ... more

Bochem Increasingly Using New Media

Bochem Instrumente GmbH presents sections of its overall product spectrum in various new videos. The recently finished productions provide a compact overview of the product groups of lab jacks, electrical lifts, containers as well as stands and clamps. They can be found on the company’s web ... more

Merger of CyBio AG into Analytik Jena AG Completed

The merger of CyBio AG into Analytik Jena AG became effective upon entry into the commercial register of Analytik Jena AG (commercial register of the Registry Court of Jena, HRB 200027). As a result, CyBio AG is dissolved as an independent company. In the future, the Life Science business u ... more

LABVOLUTION – the new lab technology show in Hannover

Deutsche Messe is launching LABVOLUTION, a new trade fair to be staged every two years as amajor platform for the world of lab technology and equipment. LABVOLUTIONmakes its debut from 6 to 8 October 2015 at the Hannover Exhibition Center in Hannover, Germany, where it will take place every ... more

Automating Laboratory-On-A-Chip To Cut Healthcare Costs

A research team at the University of California, Riverside has created a computer programming language that will automate “laboratory-on-a-chip” technologies used in DNA sequencing, drug discovery, virus detection and other biomedical applications.“If you think of the beginning of computers ... more

Reorganization of the Executive Board of Eppendorf AG

The Executive Board of Eppendorf AG is reshaping in order to be optimally equipped to meet the future demands of the market. Dr. Dirk Ehlers, Chairman of the Executive Board of the Eppendorf Group, will leave the company by mutual agreement. Detmar Ammermann (Chief Financial Officer) will r ... more

New microscope sees what others can't

Microscopes don't exactly lie, but their limitations affect the truths they can tell. For example, scanning electron microscopes (SEMs) simply can't see materials that don't conduct electricity very well, and their high energies can actually damage some types of samples. In an effort to ext ... more

A lab in your pocket

When you get sick, your physician may take a sample of your blood, send it to the lab and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card. These labs-on-a-chip would not only be quick— ... more

All news on lab technology

A major step forward in fight against Chikungunya fever

The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information of the trial has been presented at two international conferences. Th ... more

AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational

AMRI announced that its Albuquerque, N.M. sterile injectable facility has resumed full manufacturing operations. As previously announced, in September 2014 AMRI identified an environmental deviation in one manufacturing suite as a result of a weather related business interruption. The resul ... more

Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

Sanofi and Regeneron Pharmaceuticals, Inc. announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol (LDL-C, or "bad" cholesterol). Alirocumab is an investigational fully human monoclonal antibody ... more

Antibiotics get a “time-out”

Resistance to antibiotics is an important health concern that affects both the spread of infections, like Clostridium difficile, and the medication budget. Researchers at the McGill University Health Centre (MUHC) examined the effectiveness of adopting an antibiotic “time-out” during treatm ... more

Intercept Pharmaceuticals Appoints Lisa Bright as Head of Europe

Intercept Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases, announced the appointment of Lisa Bright as Senior Vice President and Head of Europe, effective Novemb ... more

Genzyme's Lemtrada Approved by the FDA

Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration (FDA) has approved LemtradaTM (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be rese ... more

Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics

The two U.S. FDA approved oligonucleotide-based drugs on the market both have a modified chemical backbone made of phosphorothioates. The therapeutic advantages of the phosphorothioate group and the new types of gene expression-regulation oligonucleotide drugs that it is enabling are detail ... more

Study offers new clue into how anesthesia works

Anesthesia, long considered a blessing to patients and surgeons, has been a mystery for much of its 160-plus-year history in the operating room. No one could figure out how these drugs interact with the brain to block pain and induce a coma-like, memory-free state. The debate has divided th ... more

Merck Announces Global Strategic Alliance with Pfizer

Merck (MRK GY) announced today that it has entered into a global agreement with Pfizer Inc. (NYSE:PFE) to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck as a potential treatment for multiple tumor types to accelerate the ... more

Recipharm acquires Lusomedicamenta for SEK 1 billion

The Pharmaceutical Contract Development and Manufacturing Organisation, Recipharm AB (publ) has acquired Lisbon based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A.Lusomedicamenta, together with its subsidiary, had twelve month revenues and adjusted EBITDA for non-recurring items t ... more

All news on pharma

Antibiotics get a “time-out”

Resistance to antibiotics is an important health concern that affects both the spread of infections, like Clostridium difficile, and the medication budget. Researchers at the McGill University Health Centre (MUHC) examined the effectiveness of adopting an antibiotic “time-out” during treatm ... more

New insights that link Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD)

Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein). Scie ... more

Monitoring Ebola cases in real-time

The current Ebola epidemic has shown how quickly a virus outbreak can turn into a global health crisis. To support of the fight against this epidemic, the German Centre for Infection Research (DZIF) just initiated the "EBOKON" consortium, which aims to promote Ebola research and close gaps ... more

Genetic testing for personalized nutrition leads to better outcomes

Researchers from the University of Toronto (U of T) report that personalized dietary advice based on a person's genetic makeup improves eating habits compared to current "one-size-fits-all" dietary recommendations. The findings were published in PLoS One. "We conducted the first randomized ... more

Study offers new clue into how anesthesia works

Anesthesia, long considered a blessing to patients and surgeons, has been a mystery for much of its 160-plus-year history in the operating room. No one could figure out how these drugs interact with the brain to block pain and induce a coma-like, memory-free state. The debate has divided th ... more

Study identifying cell of origin for large, disfiguring nerve tumors lays groundwork for development of new therapies

UT Southwestern Medical Center researchers have determined the specific type of cell that gives rise to large, disfiguring tumors called plexiform neurofibromas, a finding that could lead to new therapies for preventing growth of these tumors. “This advance provides new insight into the ste ... more

Mapping the spread of diarrhoea bacteria a major step towards new vaccine

Every year hundreds of thousands of people die from diarrhoeal diseases caused by ETEC bacteria. A study published in Nature Genetics describes how Swedish researchers have mapped the spread of strains of ETEC bacteria around the world. It provides key information about how pathogenic bacte ... more

UF researchers discover how to cultivate norovirus in human cells

Noroviruses are pernicious intestinal viruses. They cause violent vomiting and diarrhea, and people ill with the virus remain contagious up to three days after they seem to recover. Although a vaccine for these viruses is in clinical trials, there is still no medication to combat them. That ... more

Research on Skilled Limb Movement Wins 2014 Eppendorf & Science Prize

The US scientist Eiman Azim, Ph.D., Postdoctoral Research Fellow at Columbia University in New York has won the 2014 Eppendorf & Science Prize for Neurobiology. Dr. Azim’s work offers fundamental new insights into the neural mechanisms that enable skilled limb movements to be both smooth an ... more

Shaping up: Researchers reconstruct early stages of embryo development

Researchers at the University of Cambridge have managed to reconstruct the early stage of mammalian development using embryonic stem cells, showing that a critical mass of cells – not too few, but not too many – is needed for the cells to being self-organising into the correct structure for ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE